Type I interferon (IFN) signaling is critical for intracellular antimicrobial programmes, affecting both innate and adaptive immune responses. The paper recently published in Cell demonstrates a new regulatory mechanism of the type I IFN signaling pathway by histone-lysine N-methyltransferase SETD2.The Janus tyrosine kinase (JAK), Signal Transducer and Activator of Transcription (STAT) proteins, and Interferon Regulatory Factor (IRF) family of transcription factors are important mediators of many cytokine systems [1][2][3][4]. While cytokine research has impacted a number of fields, it is remarkable that the major cytokine pathways were first elucidated in the context of the same regulatory network, the type I interferon (IFN) system. As such, one may term the series of studies as a first wave of research on cytokine induction and action.The field may now be witnessing a so-called second wave of discovery related to how cytokine signaling systems are fine-tuned by other regulatory pathways. This is exemplified by a recent paper by Cao laboratory who demonstrate that type I IFN-induced STAT1 activation is regulated by histone-lysine N-methyltransferase SETD2 (SET domain containing 2), which has been previously characterized for its trimethylation of lysine 36 of histone H3 (H3K36) [5]. The authors first performed high-throughput screening of epigenetic modifiers by lentivirusmediated RNAi (RNA interference) to search for epigenetic factors that modu-